Mesirow Financial Investment Management, Inc. Mirum Pharmaceuticals, Inc. Transaction History

Mesirow Financial Investment Management, Inc.

$4.94 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Jan 14, 2022	SELL	$13.05 - $19.35 $336,624 - $499,133	-25,795 Closed	0 $0
Q3 2021 Oct 20, 2021	BUY	$13.95 - $20.18 $359,840 - $520,543	25,795 New	25,795 $514,000

Others Institutions Holding MIRM

# of Institutions

190

Shares Held

54M

Call Options Held

177K

Put Options Held

167K

Frazier Life Sciences Management, L.P. Menlo Park, CA

6.57M
Shares

$287 Million
13.79% of portfolio
Janus Henderson Group PLC London, X0

4.48M
Shares

$196 Million
0.09% of portfolio
Eventide Asset Management, LLC Boston, MA

3.45M
Shares

$151 Million
2.37% of portfolio
Black Rock Inc. New York, NY

3.24M
Shares

$141 Million
0.0% of portfolio
Bvf Inc San Francisco, CA

3.08M
Shares

$134 Million
3.81% of portfolio

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.61B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.

Account